Literature DB >> 19349057

Rat cytomegalovirus infection depletes MHC II in bone marrow derived dendritic cells.

Carmen C Baca Jones1, Craig N Kreklywich, Ilhem Messaoudi, Jennifer Vomaske, Erin McCartney, Susan L Orloff, Jay A Nelson, Daniel N Streblow.   

Abstract

While cytomegalovirus (CMV) infects and replicates in a multitude of cell types, the ability of the virus to replicate in antigen presenting cells (APCs) is believed to play a critical role in the viral dissemination and latency. CMV infection of APCs and manipulation of their function are important areas of investigation. CMV down regulation of MHC II is reportedly mediated by the HCMV proteins US2, US3, UL83, UL111a (vIL10) or through the induction of cellular IL10. In this study, we demonstrate that rat CMV (RCMV) significantly reduces MHC II expression neither by mechanisms that do not involve orthologues of the known HCMV genes nor by an increase in cellular IL10. Rat bone marrow derived dendritic cells (BMDC) were highly susceptible to infection with RCMV and a recombinant RCMV expressing eGFP. RCMV infection of BMDCs depleted both surface and intracellular MHC II to nearly undetectable levels as well as reduced surface expression of MHC I. The effect on MHC II only occurred in the infected GFP positive cells and is mediated by an immediate early or early viral gene product. Furthermore, treatment of uninfected immature DCs with virus-free conditioned supernatants from infected cells failed to down regulate MHC II. RCMV depletion of MHC II was sensitive to treatment with lysosomal inhibitors but not proteasomal inhibitors suggesting that the mechanism of RCMV-mediated down regulation of MHC II occurs through endocytic degradation. Since RCMV does not encode homologues of US2, US3, UL83 or UL111a, these data indicate a novel mechanism for RCMV depletion of MHC II.

Entities:  

Mesh:

Year:  2009        PMID: 19349057      PMCID: PMC2749604          DOI: 10.1016/j.virol.2009.02.050

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  44 in total

1.  A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation.

Authors:  U Reusch; W Muranyi; P Lucin; H G Burgert; H Hengel; U H Koszinowski
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

2.  A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface.

Authors:  M F Kleijnen; J B Huppa; P Lucin; S Mukherjee; H Farrell; A E Campbell; U H Koszinowski; A B Hill; H L Ploegh
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

3.  B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.

Authors:  V K Kuchroo; M P Das; J A Brown; A M Ranger; S S Zamvil; R A Sobel; H L Weiner; N Nabavi; L H Glimcher
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

4.  Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10.

Authors:  S Redpath; A Angulo; N R Gascoigne; P Ghazal
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

5.  A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments.

Authors:  H Ziegler; R Thale; P Lucin; W Muranyi; T Flohr; H Hengel; H Farrell; W Rawlinson; U H Koszinowski
Journal:  Immunity       Date:  1997-01       Impact factor: 31.745

Review 6.  Interaction of human cytomegalovirus with monocytes/macrophages: a love-hate relationship.

Authors:  S Michelson
Journal:  Pathol Biol (Paris)       Date:  1997-02

7.  Pathogenesis of experimental rhesus cytomegalovirus infection.

Authors:  K M Lockridge; G Sequar; S S Zhou; Y Yue; C P Mandell; P A Barry
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

8.  Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.

Authors:  K Ahn; A Angulo; P Ghazal; P A Peterson; Y Yang; K Früh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells.

Authors:  Andrea Loewendorf; Corinna Krüger; Eva Maria Borst; Markus Wagner; Ursula Just; Martin Messerle
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

10.  Human cytomegalovirus persistently infects aortic endothelial cells.

Authors:  K N Fish; C Soderberg-Naucler; L K Mills; S Stenglein; J A Nelson
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more
  9 in total

1.  Fluorescence-based laser capture microscopy technology facilitates identification of critical in vivo cytomegalovirus transcriptional programs.

Authors:  Craig N Kreklywich; Patricia P Smith; Carmen Baca Jones; Anda Cornea; Susan L Orloff; Daniel N Streblow
Journal:  Methods Mol Biol       Date:  2014

2.  Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.

Authors:  Praneet K Sandhu; Nicholas J Buchkovich
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

3.  Cellular distribution of CD200 receptor in rats and its interaction with cytomegalovirus e127 protein.

Authors:  Mohamed A El-Mokhtar; Agnieszka Bauer; Julia Madela; Sebastian Voigt
Journal:  Med Microbiol Immunol       Date:  2018-07-21       Impact factor: 3.402

4.  Cytomegalovirus CC chemokine promotes immune cell migration.

Authors:  Jennifer Vomaske; Michael Denton; Craig Kreklywich; Takeshi Andoh; Jessica M Osborn; Daniel Chen; Ilhem Messaoudi; Susan L Orloff; Daniel N Streblow
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

Review 5.  Cytomegalovirus immune evasion by perturbation of endosomal trafficking.

Authors:  Pero Lučin; Hana Mahmutefendić; Gordana Blagojević Zagorac; Maja Ilić Tomaš
Journal:  Cell Mol Immunol       Date:  2014-09-29       Impact factor: 11.530

6.  Cytomegalovirus Infection of the Rat Developing Brain In Utero Prominently Targets Immune Cells and Promotes Early Microglial Activation.

Authors:  Robin Cloarec; Sylvian Bauer; Hervé Luche; Emmanuelle Buhler; Emilie Pallesi-Pocachard; Manal Salmi; Sandra Courtens; Annick Massacrier; Pierre Grenot; Natacha Teissier; Françoise Watrin; Fabienne Schaller; Homa Adle-Biassette; Pierre Gressens; Marie Malissen; Thomas Stamminger; Daniel N Streblow; Nadine Bruneau; Pierre Szepetowski
Journal:  PLoS One       Date:  2016-07-29       Impact factor: 3.240

7.  Rat Cytomegalovirus Virion-Associated Proteins R131 and R129 Are Necessary for Infection of Macrophages and Dendritic Cells.

Authors:  Iris K A Jones; Nicole N Haese; Philippe Gatault; Zachary J Streblow; Takeshi F Andoh; Michael Denton; Cassilyn E Streblow; Kiley Bonin; Craig N Kreklywich; Jennifer M Burg; Susan L Orloff; Daniel N Streblow
Journal:  Pathogens       Date:  2020-11-19

8.  In Utero Administration of Drugs Targeting Microglia Improves the Neurodevelopmental Outcome Following Cytomegalovirus Infection of the Rat Fetal Brain.

Authors:  Robin Cloarec; Sylvian Bauer; Natacha Teissier; Fabienne Schaller; Hervé Luche; Sandra Courtens; Manal Salmi; Vanessa Pauly; Emilie Bois; Emilie Pallesi-Pocachard; Emmanuelle Buhler; François J Michel; Pierre Gressens; Marie Malissen; Thomas Stamminger; Daniel N Streblow; Nadine Bruneau; Pierre Szepetowski
Journal:  Front Cell Neurosci       Date:  2018-03-06       Impact factor: 5.505

9.  Single cell analysis reveals human cytomegalovirus drives latently infected cells towards an anergic-like monocyte state.

Authors:  Miri Shnayder; Aharon Nachshon; Batsheva Rozman; Biana Bernshtein; Michael Lavi; Noam Fein; Emma Poole; Selmir Avdic; Emily Blyth; David Gottlieb; Allison Abendroth; Barry Slobedman; John Sinclair; Noam Stern-Ginossar; Michal Schwartz
Journal:  Elife       Date:  2020-01-22       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.